A clinical trial of adjunctive cyproheptadine in the treatment of autistic disorder: a double-blind and placebo controlled trial

被引：0
|
作者：
Akhondzadeh, S
Mohammadi, MR
Erfani, S
Tehranidoost, M
Amini, H
Kashani, L
机构：
[1] Univ Tehran Med Sci, Ctr Psychiat, Roozbeh Psychiat Hosp, Tehran, Iran
[2] Univ Tehran Med Sci, Inst Med Plants, Tehran, Iran
[3] Univ Tehran Med Sci, Vali Asr Hosp, Tehran, Iran
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2004年 / 57卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：670 / 670
页数：1
相关论文
共 50 条
  • [1] Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial
    Akhondzadeh, S
    Erfani, S
    Mohammadi, MR
    Tehrani-Doost, M
    Amini, H
    Gudarzi, SS
    Yasamy, MT
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2004, 29 (02) : 145 - 150
  • [2] Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial
    Ghaleiha, Ali
    Alikhani, Rosa
    Kazemi, Mohammad-Reza
    Mohammadi, Mohammad-Reza
    Mohammadinejad, Payam
    Zeinoddini, Atefeh
    Hamedi, Mehdi
    Shahriari, Mona
    Keshavarzi, Zahra
    Akhondzadeh, Shahin
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (09) : 784 - +
  • [3] Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
    Mahtab Asadabadi
    Mohammad-Reza Mohammadi
    Ahmad Ghanizadeh
    Amirhossein Modabbernia
    Mandana Ashrafi
    Elmira Hassanzadeh
    Saeedeh Forghani
    Shahin Akhondzadeh
    [J]. Psychopharmacology, 2013, 225 : 51 - 59
  • [4] Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
    Asadabadi, Mahtab
    Mohammadi, Mohammad-Reza
    Ghanizadeh, Ahmad
    Modabbernia, Amirhossein
    Ashrafi, Mandana
    Hassanzadeh, Elmira
    Forghani, Saeedeh
    Akhondzadeh, Shahin
    [J]. PSYCHOPHARMACOLOGY, 2013, 225 (01) : 51 - 59
  • [5] Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
    Ghaleiha, Ali
    Asadabadi, Mahtab
    Mohammadi, Mohammad-Reza
    Shahei, Maryam
    Tabrizi, Mina
    Hajiaghaee, Reza
    Hassanzadeh, Elmira
    Akhondzadeh, Shahin
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (04): : 783 - 789
  • [6] A double-blind placebo-controlled trial of risperidone in autistic disorder
    McDougle, C
    Aman, MG
    McCracken, JT
    Scahill, L
    Tierney, E
    Vitiello, B
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S327 - S328
  • [7] A clinical trial of adjunctive celecoxib treatment in patients with chronic schizophrenia: a double-blind and placebo controlled trial
    Akhondzadeh, S.
    Tabatabaee, M.
    Amini, H.
    Ahmadi-Abhari, S. A.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (06) : 774 - 774
  • [8] Riluzole as an Adjunctive Therapy to Risperidone for the Treatment of Irritability in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial
    Ghaleiha, Ali
    Mohammadi, Effat
    Mohammadi, Mohammad-Reza
    Farokhnia, Mehdi
    Modabbernia, Amirhossein
    Yekehtaz, Habibeh
    Ashrafi, Mandana
    Hassanzadeh, Elmira
    Akhondzadeh, Shahin
    [J]. PEDIATRIC DRUGS, 2013, 15 (06) : 505 - 514
  • [9] Riluzole as an Adjunctive Therapy to Risperidone for the Treatment of Irritability in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial
    Ali Ghaleiha
    Effat Mohammadi
    Mohammad-Reza Mohammadi
    Mehdi Farokhnia
    Amirhossein Modabbernia
    Habibeh Yekehtaz
    Mandana Ashrafi
    Elmira Hassanzadeh
    Shahin Akhondzadeh
    [J]. Pediatric Drugs, 2013, 15 : 505 - 514
  • [10] Secretin in children with autistic disorder: A double-blind, placebo-controlled trial
    Handen, BL
    Hofkosh, D
    [J]. JOURNAL OF DEVELOPMENTAL AND PHYSICAL DISABILITIES, 2005, 17 (02) : 95 - 106
12345